In a latest development a new lawsuit joins the Federal Multi-district Litigation Court when a plaintiff from Kentucky filed a lawsuit against the drug maker Boehringer Ingelheim for not informing people about the potential side effects of the drug.

According to reports, the was filed on January 15, 2013 in the United States’ District Court for the Southern District of Illinois, by a resident of Kentucky. In the lawsuit, the plaintiff has stated that he started taking Pradaxa a few years back on the advice of his doctor to treat Atrial fibrillation, however, the anticoagulant responded differently in his body and caused him to suffer severe gastrointestinal bleeding. The plaintiff was then admitted to the hospital and received blood transfusions and other procedures to stop the bleeding.

In the lawsuit the plaintiff and his Pradaxa lawyer has framed a number of charges against the defendant Boehringer Ingelheim and stated that the drug maker should have adequately informed patients about the potential side effects that the drug poses to patients, particularly gastrointestinal bleeding that could potentially lead to death. With the lawsuit, the plaintiff has brought in a number counts against the defendant including breach of product liability, misrepresentation of clinical research data, and concealment of relevant information. The plaintiff has sought for compensatory, punitive and exemplary damages with the lawsuit.

About Pradaxa

Pradaxa is a widely prescribed anticoagulant or blood thinner that is manufactured and marketed by pharmaceutical giant Boehringer Ingelheim. In last few years the drug has appeared as one of the most potential alternatives to Warfarin. However, Pradaxa has been criticized by patients and doctors for its potential link to side effects like gastrointestinal bleeding.

Pradaxa is a Dabigatran that keeps the platelets in your blood from coagulating or commonly called as clotting. The drug is being used by doctors and medical experts to prevent the formation of blood clot in the body and to reduce the risks of in people suffering from heart related complications.

Some are:

  • Passage of blood with stool or urine
  • Passing of tarry or black stools
  • Weakness
  • Non-stop bleeding
  • Passage of blood through vagina, nose or mouth
  • Appearance of red or purple spots under the skin
  • Vomiting and coughing up blood
  • Joint pains
  • Unusual and heavy menstrual bleeding